FACULTY
Stephen M. Setter, PharmD, CDE, CGP, FASCP
Associate Professor of Pharmacotherapy
Washington State University
Spokane, WA
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors,
planners, managers, and other individuals who are in a position to control the content of
CME activities. All relevant conflicts of interest that are identified are thoroughly vetted
by PIM for fair balance, scientific objectivity of studies utilized in this activity, and
patient care recommendations. PIM is committed to providing its learners with high
quality CME activities and related materials that promote improvements or quality in
health care and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or
devices they or their spouse/life partner have with commercial interests related to the
content of this CME activity:
| Name of Faculty or Presenter |
Reported Financial Relationship |
| Stephen M. Setter, PharmD |
Member of Speakers’ Bureau, Teva Neuroscience |
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Planner or Manager |
Reported Financial Relationship |
| Linda Graham, RN, BSN, BA |
No real or apparent conflicts of interest to report. |
| Joseph Cupolo, MA, MS |
No real or apparent conflicts of interest to report. |
ACCREDITATION
STATEMENTS
Pharmacy
Postgraduate Healthcare Education, LLC
is accredited by the Accreditation Council for Pharmacy Education
as a provider of continuing pharmacy education.
Program No.: 430-000-08-004-H01-P; 430-000-08-004-H01-T
Credits: 2.0 hours (0.20 ceu)
| Published: March 1, 2008 |
Expires: March 31, 2010 |
ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas
and Policies of the Accreditation Council for Continuing Medical Education (ACCME)
through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and
Postgraduate Healthcare Education, LLC. PIM is accredited by the ACCME to provide
continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of
1.5 AMA PRA Category 1 Credit(s).™ Physicians should only claim credit commensurate
with the extent of their participation in the activity.
Media:
Monograph
Estimated time to complete activity:
Estimated time to complete this program and posttest is 90 to 120 minutes.
Exam processing inquiries and booklet orders to:
CE Customer Service Manager (800) 825-4696
Direct educational content inquiries to:
CE Director (800) 331-9396
PROCEDURE
Please complete the postest questions and program evaluation online at:
www.powerpak.com (a username and password are required to access your account).
Upon passing the exam with a score of 70% or better, you can print out your statement
of credit immediately. You can also view your tst history at any time and print
out duplicate statements from the Web site.
| Release Date: March 1, 2008 |
Expiration Date: March 31, 2009 |
TARGET AUDIENCE
This activity has been designed to meet the educational needs of pharmacists, pharmacy technicians, physicians, physician assistants, and nurse practitioners involved in the
management of patients with Parkinson’s disease.
STATEMENT OF NEED/PROGRAM OVERVIEW
This program has been developed to provide participants with an update on the management
of PD, guidelines for appropriate selection of therapy, and strategies for enhancing
patient adherence.
EDUCATIONAL OBJECTIVES
After completing this program, participants will be able to:
- Describe the prevalence and diagnosis of PD*
- Recount the implications of non-adherence to pharmacological therapy*
- Outline the efficacy and safety of current agents for the management of PD*
- Review guidelines for appropriate selection of therapy*
- Describe strategies for enhancing patient adherence
*Also applies to pharmacy technicians.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Postgraduate Healthcare Education
(PHE), and Teva Neuroscience do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, PHE, and Teva Neuroscience. Please refer to the official prescribing information for each
product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as
a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s
conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities..
